Novartis' recent Gilenya patent win slips away after appeals court reverses its own prior verdict

After handing Novartis a win in January, a U.S. appeals court has changed course in a Gilenya patent infringement lawsuit. On Tuesday, the judges revived a Chinese drugmaker’s bid to challenge the blockbuster multiple sclerosis med with its copycat.